Samuel Agresta
Nessuna posizione attualmente
Patrimonio netto: 1 $ in data 31/01/2024
Storia della carriera di Samuel Agresta
Precedenti posizioni note di Samuel Agresta
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| FOGHORN THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 01/09/2019 | 11/09/2023 |
| INFINITY PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 16/10/2019 | 24/07/2023 |
| Direttore Tecnico/Scientifico/R&S | 07/08/2018 | 16/10/2019 | |
| AGIOS PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2011 | 01/08/2018 |
| MERRIMACK PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/11/2010 | 01/12/2011 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Direttore Tecnico/Scientifico/R&S | 01/11/2007 | 01/12/2010 |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
 H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Corporate Officer/Principal | 01/08/2004 | 01/11/2010 |
Formazione di Samuel Agresta
| Georgetown University | Undergraduate Degree |
| Tulane University School of Medicine | Doctorate Degree |
| Tulane University School of Public Health & Tropical Medicine | Graduate Degree |
| University of South Florida | Graduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 11 |
Posizioni
| Chief Tech/Sci/R&D Officer | 5 |
| Graduate Degree | 2 |
| Director/Board Member | 1 |
Settori
| Health Technology | 6 |
| Consumer Services | 5 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| INFINITY PHARMACEUTICALS, INC. | Health Technology |
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| FOGHORN THERAPEUTICS INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
H. Lee Moffitt Cancer Center & Research Institute, Inc.
H. Lee Moffitt Cancer Center & Research Institute, Inc. Miscellaneous Commercial ServicesCommercial Services H. Lee Moffitt Cancer Center & Research Institute, Inc. provides research & contributions to clinical trials, prevention and cancer control. The firm operates as National Cancer Institute (NCI) Comprehensive Cancer Center. The company was founded by Lee H. Moffitt in 1981 and is headquartered in Tampa, FL. | Commercial Services |
- Borsa valori
- Insiders
- Samuel Agresta
- Esperienza